Option Care Health, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Option Care Health, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $5.00B | Feb 26, 2025 |
| FY2024 | Dec 31, 2023 | $4.30B | Feb 26, 2025 |
| FY2024 | Dec 31, 2022 | $3.94B | Feb 26, 2025 |
| FY2011 | Dec 31, 2011 | $1.82B | Mar 14, 2012 |
| FY2011 | Dec 31, 2010 | $1.64B | Mar 14, 2012 |
| FY2011 | Dec 31, 2009 | $1.33B | Mar 14, 2012 |
| FY2009 | Dec 31, 2008 | $1.40B | Mar 2, 2010 |
| FY2009 | Dec 31, 2007 | $1.20B | Mar 2, 2010 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.65B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $5.00B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $4.30B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $3.87B | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $3.44B | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $804.71M | Mar 11, 2021 |
| FY2020 | Sep 30, 2020 | $781.61M | Mar 11, 2021 |
| FY2020 | Jun 30, 2020 | $740.85M | Mar 11, 2021 |
| FY2020 | Mar 31, 2020 | $705.44M | Mar 11, 2021 |
| FY2020 | Dec 31, 2019 | $720.78M | Mar 11, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.09B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.01B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $981.22M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $866.92M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $779.61M | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $183.76M | Mar 11, 2021 |
| FY2020 | Sep 30, 2020 | $174.15M | Mar 11, 2021 |
| FY2020 | Jun 30, 2020 | $166.32M | Mar 11, 2021 |
| FY2020 | Mar 31, 2020 | $158.03M | Mar 11, 2021 |
| FY2020 | Dec 31, 2019 | $175.64M | Mar 11, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $207.59M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $211.82M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $267.09M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $150.56M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $139.90M | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $17.84M | Mar 11, 2021 |
| FY2020 | Sep 30, 2020 | $1.66M | Mar 11, 2021 |
| FY2020 | Jun 30, 2020 | ($7.67M) | Mar 11, 2021 |
| FY2020 | Mar 31, 2020 | ($19.91M) | Mar 11, 2021 |
| FY2020 | Dec 31, 2019 | ($15.81M) | Mar 11, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $337.91M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $321.83M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $314.60M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $240.23M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $190.84M | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $44.34M | Mar 11, 2021 |
| FY2020 | Sep 30, 2020 | $34.56M | Mar 11, 2021 |
| FY2020 | Jun 30, 2020 | $23.21M | Mar 11, 2021 |
| FY2020 | Mar 31, 2020 | $8.65M | Mar 11, 2021 |
| FY2020 | Dec 31, 2019 | $13.97M | Mar 11, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $682.45M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $630.25M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $607.43M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $566.12M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $525.71M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $500.20M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $459.63M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $345.88M | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | $338.46M | Mar 5, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $258.45M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $323.39M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $371.30M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $267.55M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $208.57M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $127.39M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $39.47M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $24.43M | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | $37.87M | Mar 5, 2020 |
| FY2018 | Dec 31, 2016 | ($42.54M) | Mar 15, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $41.31M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $35.61M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $41.87M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $35.36M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $25.63M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $26.88M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $28.29M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $26.28M | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | $24.96M | Mar 5, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.46B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $3.42B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $3.22B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $3.11B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $2.79B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $2.65B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $2.59B | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $1.43B | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $603.09M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $604.99M | Mar 26, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.13B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.02B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $1.80B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $1.73B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.62B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.63B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $1.68B | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $825.39M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $605.77M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $566.60M | Mar 26, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.33B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.40B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $1.42B | Feb 24, 2026 |
| FY2025 | Dec 31, 2022 | $1.39B | Feb 24, 2026 |
| FY2024 | Dec 31, 2021 | $1.18B | Feb 26, 2025 |
| FY2023 | Dec 31, 2020 | $1.02B | Feb 22, 2024 |
| FY2022 | Dec 31, 2019 | $906.83M | Feb 23, 2023 |
| FY2021 | Dec 31, 2018 | $602.83M | Feb 23, 2022 |
| FY2019 | Jun 30, 2018 | $602.83M | Mar 5, 2020 |
| FY2020 | Dec 31, 2017 | $606.11M | Mar 11, 2021 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.61B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.54B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $1.54B | Feb 24, 2026 |
| FY2025 | Dec 31, 2022 | $1.53B | Feb 24, 2026 |
| FY2024 | Dec 31, 2021 | $1.48B | Feb 26, 2025 |
| FY2023 | Dec 31, 2020 | $1.43B | Feb 22, 2024 |
| FY2022 | Dec 31, 2019 | $1.43B | Feb 23, 2023 |
| FY2021 | Dec 31, 2018 | $632.47M | Feb 23, 2022 |
| FY2020 | Dec 31, 2017 | $627.39M | Mar 11, 2021 |
| FY2018 | Dec 31, 2016 | $365.95M | Mar 15, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $876.92M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $669.34M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $457.51M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $190.42M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $39.87M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | ($100.03M) | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | ($91.96M) | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | ($16.04M) | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | ($709.51M) | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | ($645.32M) | Mar 26, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $232.62M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $412.57M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $343.85M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $294.19M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $119.42M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $99.27M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $67.06M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $36.39M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $39.46M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $9.57M | Mar 26, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.16B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.11B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $1.06B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $1.06B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.07B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.12B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $1.29B | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $539.38M | Mar 5, 2020 |
| FY2017 | Dec 31, 2017 | $502.86M | Mar 26, 2018 |
| FY2016 | Dec 31, 2016 | $467.72M | Mar 7, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Mar 11, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 11, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 11, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 11, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 11, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Mar 11, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 11, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 11, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 11, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 11, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 156.86M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 166.26M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | 174.58M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | 181.96M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | 179.93M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 179.79M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | 176.59M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | 142.61M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | 127.63M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | 117.68M | Mar 26, 2018 |